From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.

Area of Science:

• Uro-oncology
• Molecular diagnostics
• Genomics

Background:

• Bladder cancer diagnosis and monitoring rely on invasive procedures and less sensitive biomarkers.
• Emerging technologies are needed to improve early detection and personalized treatment strategies.

Purpose of the Study:

• To review the evolving applications of urinary tumor DNA (utDNA) in bladder cancer management.
• To highlight recent advancements in utDNA for diagnosis, monitoring, and treatment.
• To explore the potential of utDNA in facilitating personalized patient care.

Main Methods:

• Literature review focusing on recent studies of utDNA in bladder cancer.
• Analysis of utDNA's diagnostic and prognostic capabilities compared to existing biomarkers.
• Evaluation of utDNA's potential for non-invasive tumor analysis.

Main Results:

• utDNA demonstrates high potential as a leading biomarker in bladder cancer due to direct tumor-urine interaction.
• utDNA exhibits superior sensitivity compared to urine cytology, particularly in early-stage disease.
• utDNA provides comprehensive genomic and epigenetic information, enabling real-time tumor biology analysis.

Conclusions:

• utDNA offers a promising non-invasive approach to enhance all stages of bladder cancer care.
• Further clinical trials are necessary to validate utDNA's utility and revolutionize bladder cancer management.
• utDNA is poised to significantly advance personalized treatment strategies for bladder cancer patients.